Gynecology & Obstetrics in California

Omnimate Enterprise Co., LTD. is a Taiwan-based medical device manufacturer specializing in consumable products and contract manufacturing. The company produces endotracheal tubes (ETT) with suction and water lumens, manual hand suction devices, protective eyewear masks, mucosal intranasal drug delivery systems (MIRAD), and gynecological examination instruments including vaginal specula. Omnimate operates as a contract manufacturer offering custom part design and production from prototype through series production, with documented quality management aligned to ISO 13485, IQC/IPQC/FQC protocols, and AQL 1.0 S4 standards. The company provides EO (ethylene oxide) sterilization services in addition to manufacturing capabilities. Products are positioned for hospital, clinic, and home care markets requiring single-use, disposable medical supplies. The firm emphasizes supply chain security, flexible manufacturing responsiveness, and experienced R&D support for product development.

Alira Medical Devices is a US-based manufacturer and supplier of high-quality surgical instruments and medical devices headquartered in Sherman Oaks, California. The company serves medical practitioners across multiple specialties including plastic surgery, liposuction, gynecology, breast surgery, dental surgery, rhinoplasty, and ophthalmology. Alira offers an extensive catalog of surgical instruments—including forceps, retractors, scissors, bone instruments, electrosurgical instruments, and specialty tools—alongside advanced surgical equipment such as endoscopic systems, anesthesia workstations, ultrasound systems, and patient monitoring solutions. The company is also an authorized distributor of premium brands including Mindray, Nouvag AG, Tuttnauer, Aesthetics Biomedical, and Woodpecker. Beyond product supply, Alira provides comprehensive instrument repair services for both proprietary and third-party equipment, emphasizing quality, precision, and customer service as core differentiators.

Embolx Inc. is a medical device company specializing in advanced microcatheters for arterial embolization procedures. As a subsidiary of Edwards Lifesciences, the company develops innovative solutions for interventional oncology and related specialties, including treatments for cancerous tumors, benign prostatic hyperplasia (BPH), and uterine fibroids. The flagship product, Sniper® Balloon Occlusion Microcatheter, enables precise delivery of embolic agents with controlled blood flow pressure management. The latest generation, Sniper G3 (launched July 2025), offers improved efficiency and ease of use for healthcare providers. Embolx products are available in US and European markets and serve interventional radiologists and specialists performing minimally invasive embolization procedures.

Accurate Surgical & Scientific Instruments Corp. (ASSI) is a leading manufacturer of precision surgical instruments for specialized surgical disciplines. With nearly four decades of industry experience, ASSI supplies a comprehensive range of expertly crafted instruments including bipolar and monopolar forceps, scissors, needle holders, retractors, microvascular clamps, and specialty tools for microsurgery, hand surgery, neurosurgery, plastic and reconstructive surgery, ophthalmology, ENT, urology, and vascular surgery. The company emphasizes precision engineering, quality materials (stainless steel, titanium, insulated variants), and customer service. Products span electrosurgical instruments, bone and soft tissue surgery tools, and specialized microsurgical equipment. ASSI operates manufacturing and distribution facilities on both US coasts with B2B direct sales to hospitals, surgical centers, and medical professionals.

Fziomed, Inc. is a global leader in surgical adhesion prevention, founded in 1996 and headquartered in San Luis Obispo, California. The company specializes in developing, manufacturing, and commercializing surgical biomaterials designed to prevent postsurgical adhesions—a common complication following surgical procedures. Fziomed's products utilize proprietary dual-polymer gel technology to create clear, absorbable formulations that provide temporary tissue separation during the healing process, significantly reducing adhesion formation. The company's flagship product, Oxiplex® gel, received FDA De Novo classification and marketing authorization in July 2025 for reducing postoperative leg pain and neurological symptoms in adult patients undergoing lumbar spine procedures. Fziomed's adhesion barrier products are marketed in over 70 countries and have been utilized in nearly 1 million procedures worldwide since 2002. The product portfolio addresses multiple surgical disciplines including spine surgery, tendon and peripheral nerve procedures, intrauterine surgery, and abdominal/pelvic procedures. With approximately 59 employees, Fziomed maintains full control over both manufacturing and commercialization of its innovative surgical solutions.

Channel Medsystems develops and markets Cerene®, an endometrial cryotherapy system for the treatment of heavy menstrual bleeding and menstrual pain in women. Cerene is a minimally invasive, office-based procedure using cooling technology that requires no anesthesia or incisions and can be completed in approximately 2.5 minutes. The device is designed for gynecologists and OB/GYN practices to offer patients a treatment option that provides durable symptom relief, with clinical data showing the majority of treated patients reporting normal, light, or no periods within one year, with sustained results at three years. The company positions Cerene as a solution for the estimated 1 in 5 women who suffer from abnormal uterine bleeding, enabling patients to resume normal daily activities without the burden of heavy menstrual bleeding.

MacroLux Medical Technology Co., Ltd. is a China-based manufacturer focused on endoscopic diagnosis and treatment solutions. The company specializes in the design and development of single-use electronic endoscope products for minimally invasive procedures across multiple clinical specialties. Primary product lines include flexible ureteroscopes (CoralView U Series), airway management endoscopes, gynecological endoscopes, and ENT endoscopes. The CoralView U Series features advanced capabilities including digital imaging, adjustable bending with BendForce Enhancement Technology, and various French sizes (7.5Fr and others) optimized for different anatomical access. MacroLux serves global healthcare markets and participates in major international medical conferences including EAU, ESGE, and MEDICA, indicating significant market presence in Europe and beyond. The company has secured Series B+ venture funding from B Capital as of January 2025, supporting continued global expansion. Manufacturing and distribution are based in Shenzhen, China. While specific regulatory certifications (FDA, CE, ISO) are not explicitly mentioned in the fetched content, the participation in European medical conferences suggests alignment with relevant regulatory requirements. The company emphasizes innovation in minimally invasive urology and women's health endoscopy.

BonRay Bio is a medical device company specializing in male reproductive health diagnostics and solutions. Founded in 2016 and based in Taiwan with US operations, the company develops precision medical equipment and automated solutions addressing male infertility. The company's core expertise centers on sperm analysis and optical diagnostic technology. Product portfolio includes routine sperm testing systems, advanced sperm DNA fragmentation detection equipment, and semen processing/washing devices. BonRay Bio serves reproductive medicine clinics, fertility centers, and andrology laboratories globally. The company has secured FDA clearance and holds CE marking, indicating regulatory compliance for US and European markets. Leadership team comprises professionals with over 10 years of medical device development experience. The company positions itself as a leader in sperm diagnostics and optical technology innovation, addressing the growing global demand for male infertility solutions. Recent activities include participation in major international reproductive medicine conferences (ESHRE, CSRM, Medica) and listing on public markets in Taiwan (December 2024). BonRay Bio's LensHooke product line represents their integrated approach to male reproductive diagnostics.

Claria Medical develops the Claria System, an intelligent surgical platform designed for safe, minimally-invasive hysterectomy and related gynecological procedures. The system enables extraction of enlarged uteri using a vaginal approach without mini-laparotomy, addressing key clinical challenges in current hysterectomy techniques: container breach risks (potential for hidden cancer spread or bowel injury), significant abdominal scarring, and variable procedure times. The Claria System features redundant safety mechanisms for breach-resistant tissue containment, integrated lighting and blade technology within a large-bore handpiece for rapid extraction of large tissue volumes, and simplified handling to reduce procedural variability. The company has received prestigious National Science Foundation (NSF) and National Institute of Health (NIH) grants for product development. The platform is supported by published clinical evidence, including case reports from international surgical centers (Sydney Women's Endosurgery Centre, Hospital Angeles Morelia), a 30-surgeon usability study, and microbiological studies validating container integrity. Claria Medical targets gynecological surgeons, minimally-invasive surgery specialists, and hospital surgical departments seeking to improve hysterectomy outcomes, reduce patient recovery time, and minimize complications associated with tissue extraction and specimen containment.

Caldera Medical is a U.S.-based medical device manufacturer headquartered in Westlake Village, California, specializing in minimally invasive surgical solutions for women's pelvic health. Founded in 2002, the company develops and markets innovative products for stress urinary incontinence (SUI), pelvic organ prolapse (POP), and hysteroscopic tissue removal. The company's product portfolio includes the Desara® Family for SUI treatment, the Vertessa® Family for POP repair, the Benesta Family for hysteroscopic procedures, and the Luminelle system launched in 2024 for advanced gynecological applications. Recognized as the fastest-growing women's health company for three consecutive years, Caldera Medical emphasizes surgeon collaboration, physician training, and clinical support. The company is committed to improving patient outcomes through durable, effective minimally invasive treatments while supporting a global humanitarian program aimed at reaching one million women with pelvic health education and treatment by 2027.

Boston Scientific Corporation is a global medical device manufacturer serving multiple clinical specialties including cardiology, urology, gastroenterology, interventional radiology, electrophysiology, neurology, pain management, vascular surgery, and structural heart disease. The company manufactures and distributes a broad portfolio of minimally invasive medical devices, including cardiac rhythm management systems, interventional cardiology devices, electrophysiology catheters and mapping systems, spinal cord stimulation systems for pain management, urological devices, endoscopy and visualization systems, defibrillators, and interventional oncology equipment. Boston Scientific operates a healthcare professional portal providing online training through EDUCARE, e-commerce ordering, reimbursement resources, and comprehensive customer support with specialty-specific representative contact networks. The organization serves hospitals, ambulatory surgery centers, and healthcare professionals across the United States through direct sales and support teams organized by medical specialty. Products undergo rigorous regulatory compliance (FDA 510(k), international certifications) and the company emphasizes quality assurance and product safety as core organizational values. Customer care is available via a dedicated U.S. customer service line, with extended business hours Monday–Friday.

Prosurg, Inc is a Silicon Valley-based privately held medical device manufacturer specializing in minimally invasive surgical products for urology and gynecology. The company develops and markets endoscopic instruments and electrosurgical accessories compatible with standard endoscopic platforms and RF generators. Primary product lines include the NeoScope family of single-use rigid and flexible video endoscopes (FDA-cleared), Salinetrode electrosurgical instruments for radiofrequency ablation, and Salinetrode Flex devices. Core applications include minimally invasive prostate surgery, abnormal uterine bleeding treatment, and other urological and gynecological disorders. The company's technology platform integrates with commercially available endoscopic systems, enabling adoption in existing OR environments without capital equipment replacement. Founded in Silicon Valley, Prosurg maintains focus on developing proprietary instruments that expand the scope of minimally invasive techniques in urological and gynecological surgery.

New Deantronics is a medical device developer and manufacturer founded in San Francisco in 1985, with engineering and manufacturing operations in Taiwan and a state-of-the-art 200,000 sq. ft. facility in Spanish Springs, Nevada. The company specializes in designing, developing, and manufacturing innovative surgical and medical devices for use in general surgery, neurosurgery, cardiology, orthopedics, and aesthetic medicine. New Deantronics is particularly known for miniaturized medical devices, including nano cameras used in minimally invasive surgical procedures. The company offers comprehensive services including design, development, manufacturing, packaging, sterilization, regulatory compliance, and post-market support. The company emphasizes quality, precision, and innovation, with a strong focus on FDA and ISO 13485 regulatory compliance. New Deantronics also operates medical device incubation centers to support startup innovation in the medical device sector.

Qvin develops non-invasive diagnostic solutions leveraging menstrual blood biomarkers for women's health screening and disease monitoring. The company's flagship product, the Q-Pad, is an FDA-cleared diagnostic menstrual pad that passively collects menstrual blood via an embedded Dried Menstrual Sample strip, enabling at-home collection of clinically valuable biospecimens without needles or invasive procedures. The Q-Pad has demonstrated strong clinical correlation with venous blood samples for biomarkers including HbA1c (r=0.96), TSH, and AMH (r>0.9), supporting its use in detecting and monitoring multiple conditions including diabetes, cervical cancer (HPV detection), endometriosis, sexually transmitted infections, and uterine fibroids. Qvin's research indicates menstrual effluent contains endometrial cells, immune components, hormones, and protein biomarkers reflective of both gynecological and systemic health, positioning it as an alternative to invasive biopsies, needle-based blood collection, and speculum-driven examinations such as Pap smears. The company partners with diagnostic platforms, healthcare organizations, and research institutions to expand the clinical validation and deployment of menstrual blood-based diagnostics. Qvin targets the women's health market, particularly addressing diagnostic access gaps in underserved populations. The company maintains an active research collaboration program with scientists, foundations, and non-profits to support clinical validation studies and innovation in period-blood diagnostics.

Hologic, Inc. is a global medical technology company founded in 1985, headquartered in Redwood City, California, that specializes in diagnostics, surgical, and medical imaging technologies focused on women's health. The company develops and manufactures innovative platforms for the detection, diagnosis, and treatment of health conditions affecting women across all life stages, with particular expertise in breast health and cancer screening. Hologic's portfolio includes advanced mammography systems with integrated AI-powered detection technology, diagnostic devices, and surgical solutions. The company holds over 4,100 patents and operates in 36 countries with approximately 7,000 employees. Hologic's technology platforms emphasize early detection and proactive treatment to improve clinical outcomes and raise the standard of care globally. The company maintains regulatory compliance through FDA approvals and international certifications. In 2025, Hologic was acquired by Blackstone and TPG, becoming a privately held company. Hologic serves hospitals, imaging centers, diagnostic laboratories, and healthcare systems worldwide, with particular focus on women's preventive health, oncology, and reproductive health markets.

Labo America (operating under the Labomed® brand) manufactures precision microscopes for medical, laboratory, and industrial applications. The company has operated for over 65 years and maintains a global presence with clients in more than 200 countries and approximately 1,500 employees worldwide. Their product portfolio includes dental operating microscopes (widely used in endodontics and surgical dentistry), medical microscopes for clinical diagnostics, ENT microscopes for otolaryngology procedures, laboratory microscopes for biotech and pharmaceutical research, and industrial microscopes. The company emphasizes optical precision through proprietary MaxLite Optics coating technology, ergonomic design, and competitive value pricing. Product lines feature zoom-focus capabilities, electromagnetic braking systems, LED illumination, and adjustable focal distances accommodating multiple users. Labomed microscopes are recognized for edge-to-edge optical sharpness and reliability in high-magnification clinical applications. The company provides local installation, customization services (including custom arm lengths to accommodate clinic layouts), and comprehensive service and support. While specific regulatory certifications (FDA, ISO, CE) are not detailed on the homepage, the company serves established dental practices, medical institutions, and research facilities globally, indicating compliance with relevant medical device standards.

Cognoa is a pediatric behavioral health company developing AI-powered digital diagnostics and therapeutics for early childhood developmental conditions, with a focus on autism spectrum disorder. The company's flagship product, Canvas Dx™, is the first FDA-authorized digital diagnostic aid for autism in children aged 1.5 to 6 years, enabling remote evaluation and rapid diagnosis within days rather than months or years. Canvas Dx combines analysis of parent questionnaires and child behavior video to provide objective, data-driven diagnostic support that reduces diagnostic delays, healthcare costs, and disparities in care access—particularly for underserved and minority populations. The platform has achieved reimbursement coverage through Highmark Insurance and multiple state Medicaid programs. Beyond autism diagnostics, Cognoa is expanding its AI platform to address other pediatric behavioral health conditions including ADHD and anxiety, with a commitment to equitable, early intervention in developmental health assessment and treatment.

Bentec Medical OpCo, LLC is a medical-grade silicone fabrication and contract manufacturing specialist founded in 1994 and currently headquartered in Woodland, California. The company operates in two primary segments: (1) OEM contract manufacturing services providing silicone component fabrication, assembly, sterilization, packaging, design consultation, and regulatory support for medical device partners; and (2) proprietary FDA and CE-approved silicone medical devices distributed under the Bentec Medical brand. The company specializes in advanced silicone fabrication capabilities including micro-molding, multi-lumen extrusions, hybrid calendered sheeting, dip coating, and knife coating. Manufacturing expertise encompasses tight-tolerance components, complex multi-process assemblies, and material compounding. Bentec serves OEM customers and direct end-users across oncology, cardiology, urology, pediatrics, bariatric, general and cosmetic surgery, ENT, and interventional radiology specialties. Quality and regulatory credentials include FDA registration, ISO 13485:2016 certification, and ISO 14644 Class 7 cleanroom certification. The company maintains a track record of 100% monthly supplier scorecards from Fortune 500 OEM customers. Manufacturing capabilities combine proprietary techniques with fully validated processes and stringent environmental controls. Bentec was acquired by Hermitage/Greyrock in 2016, which implemented institutional ownership standards, enhanced engineering and quality management systems, and expanded production capacity and fabrication technology.

Avatar Medical USA Inc develops FDA-cleared and CE-marked 3D medical imaging visualization software that transforms DICOM medical images into interactive 3D patient avatars for clinical consultation, surgical planning, and medical education. The platform is hardware-agnostic and integrates with existing PACS systems without preprocessing requirements. It enables real-time 3D visualization suitable for multiple surgical specialties including neurosurgery, oncology, ENT, oral maxillofacial surgery, cardiovascular and vascular surgery, and urology. The software supports intraoperative guidance, multidisciplinary team collaboration, and patient engagement during pre- and post-operative consultations. Avatar Medical also offers Eonis Vision, a consultation-focused product, and Avatar Medical Academy for medical education. The platform supports extended reality (XR) interaction for immersive visualization. Clinical applications span from patient communication and informed consent to detailed surgical planning and training environments. The company serves major teaching hospitals and medical centers across North America and Europe, including Assistance Publique-Hôpitaux de Paris, Sorbonne University, and University of Miami.